March 26, 2026 02:22 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mamata unveils TMC candidate list for Bengal polls; to face Suvendu in Bhabanipur | ‘Not a one-day battle for me’: Mamata Banerjee on facing Suvendu Adhikari in Bhabanipur | Mamata vs Suvendu: Bhabanipur set for high-voltage showdown | Barbaric: India condemns Pakistani airstrike on Kabul hospital | Middle East conflict: Israel says it killed key Iranian commander during overnight strike | Middle East on edge: Kataeb Hezbollah commander Abu Ali al-Askari killed | Middle East on edge: Kataeb Hezbollah commander Abu Ali al-Askari killed | Afghanistan claims Pakistani airstrike on Kabul hospital left 400 killed, Islamabad denies | ECI orders major reshuffle in Bengal police brass a day after poll announcement | 10 patients killed in fire at SCB Medical College Hospital in Cuttack; staff injured

Aurobindo Pharma receives USFDA approval for pain reliever tablets

| | May 17, 2016, at 07:19 pm
Hyderabad, May 17 (IBNS) Aurobindo Pharma Limited, manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg.
Hydromorphone Hydrochloride Tablets is used to relieve moderate to severe pain in patients where the use of an opioid is appropriate, the company release said.
 
The company said that the approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Dilaudid (hydromorphone hydrochloride) Tablets, 2 mg, 4 mg, and 8 mg of Purdue Pharma L.P.
 
Quoting IMS, the company said that the approved product has an estimated market size of US$ 50 million for the twelve months ending March 2016.
 
The company also said this is the 12th ANDA to be approved out of Aurolife formulation facility in New Jersey, US for manufacturing non-antibiotic products and controlled substances, . 
 
Aurobindo now has a total of 263 ANDA approvals (225 Final approvals, including 12 from Aurolife Pharma LLC and 38 tentative approvals) from USFDA.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm